The GP contract for 2026/27 took effect on 1 April 2026, following a letter published by NHS England on 24 February 2026 (updated 4 March 2026) setting out an overall funding increase of £485 million, bringing total contract value to £13,863 million. What makes this year’s contract legally notable is not only its content, but the process behind it: unlike previous years, this round of changes was put to the profession as what the Department of Health and Social Care itself described as a consultation rather than a negotiation with the BMA’s General Practitioners Committee England, and the GPC subsequently balloted GPs on the changes, with a majority of those who voted opposed.
For a GP partnership, that shift in process matters as much as the substance. The annual contract cycle has, for years, operated on the basis of agreement between NHS England (or DHSC) and the BMA, with the resulting terms then given legal effect through amendments to the GMS Contracts Regulations 2015 and the Statement of Financial Entitlements. A move towards imposed rather than negotiated terms does not change the fact that, once the underlying regulations are amended, the terms bind practices regardless of the BMA’s position. This post sets out what changed for 2026/27, the financial detail behind the headline figures, and where practices most need to pay attention.
The Funding Headline, and Why the Real Terms Picture Is Contested
NHS England’s own description of the £485 million uplift is a 3.6% cash increase, or 1.4% real terms growth relative to the GDP deflator. Global sum, the core per-patient payment underpinning most practice income, rose from £123.34 to £130.07 per weighted patient, a net uplift of £6.73, which NHS England describes as a 5.5% GMS contract uplift, applied equally to GMS, PMS and APMS contracts from 1 April 2026.
That is NHS England’s own figure and methodology. Independent analysis published by Londonwide LMCs reaches a different real terms conclusion using a different baseline and inflation measure, calculating that against a 2.4% inflationary uplift to the prior year’s total budget, the 2026/27 contract value has in fact fallen by approximately 0.26% in real terms. Both figures cannot be reconciled without knowing the precise assumptions each methodology used, and we would treat any single “real terms” headline, from either side, with appropriate caution. What is not in dispute is the cash figures: a £485 million uplift, a global sum increase to £130.07 per weighted patient, and a QOF point value rising to £227.95.
The Practice-Level GP Reimbursement Scheme
The most structurally significant change for 2026/27 is the introduction of a new practice-level GP reimbursement scheme, replacing the PCN-level Capacity and Access Payment. NHS England has repurposed £292 million from the former PCN Capacity and Access Payment into a scheme worth £4.57 per practice adjusted population, intended to let individual practices recruit additional GP sessions to support same-day clinically urgent access, rather than relying on PCN-level arrangements.
Practices should be aware of several legal and practical conditions attached to this scheme:
- GPs employed under the scheme must be issued with a fixed-term contract of at least 6 months, on terms no less favourable than the BMA’s salaried GP model contract.
- The maximum reimbursable amount is £152,900 per annum plus on-costs (with additional London weighting), a figure NHS England subsequently corrected after an initial published hourly rate would have implied a considerably higher full-time equivalent salary than the stated maximum.
- This is not new, additional money in the sense of extra funding on top of existing PCN budgets. It is a reallocation of funding that was previously being used, in many areas, to fund PCN-level same-day access GP capacity. Practices and PCNs will need to agree how existing arrangements funded under the old Capacity and Access Payment are transitioned onto the new scheme.
- Claims must be made through CQRS and submitted within 3 months of the end of the month to which the claim relates.
For practices already employing GPs under Additional Roles Reimbursement Scheme arrangements, the removal of the restriction limiting ARRS GP funding to recently qualified doctors (previously those within 2 years of their Certificate of Completion of Training) opens up recruitment more broadly, a change we cover in more detail, including the employment law risks it raises, in our post on ARRS employment traps.
Access Requirements: Same-Day Triage Becomes Contractual
The core practice contract was amended to require that requests a practice determines to be clinically urgent must be dealt with on the same day. Practices can no longer ask patients to call back or make contact on another day. For non-urgent contacts, practices must provide patients with an appropriate response, explaining how and when the issue will be managed, by the end of the next working day. Online consultation systems must not cap the number of requests that can be submitted during core hours, putting online access on the same contractual footing as telephone and walk-in access. Where an ICB identifies unwarranted variation in a practice’s performance against these requirements, the practice is now contractually required to engage with ICB support, a provision with real teeth given its proximity to the existing breach and remedial notice framework under the GMS Contracts Regulations.
QOF and Vaccination Changes
| Area | Change for 2026/27 |
|---|---|
| Diabetes | New indicator requiring delivery of all 8 NICE-recommended care processes |
| Heart failure | Updated indicators reflecting the NICE-recommended “4 pillars” of treatment for HFrEF |
| Obesity | Two new indicators on referral to structured weight management programmes and shared decision-making on pharmacotherapy; the separate Weight Management Enhanced Service is retired |
| Blood pressure control | New combined indicators for patients without frailty, replacing the previous separate CHD and stroke/TIA indicators |
| Childhood vaccination (VI001-VI003) | New improvement-from-baseline thresholds introduced as an alternative to fixed achievement thresholds, with practices paid on whichever measure yields more points |
These changes are supported by an additional 18 QOF points, worth approximately £25 million nationally. The improvement-from-baseline mechanism for vaccination indicators is a genuinely useful change for practices in areas with historically low uptake, since it removes the previous all-or-nothing character of fixed thresholds, though the current thresholds themselves (VI001 at 89-96%, for example) remain otherwise unchanged.
Other Contractual Changes Worth Noting
- Subcontracting powers aligned across GMS and PMS. The PMS Regulations are being amended to mirror the GMS Regulations, giving commissioners equivalent powers to object to subcontracting arrangements where patient safety, financial risk, or delivery of contractual obligations may be affected.
- Advice and Guidance embedded in core funding. Previously a separately funded enhanced service, Advice and Guidance now sits within core practice funding and becomes a “should do” requirement before, or instead of, a planned care referral where clinically appropriate.
- Online registration mandated. Practices must use the national online registration system for all registrations, including transcribing paper forms where a patient cannot register online themselves.
- RSV vaccination cohort extended to all adults aged 80 and over and all residents in care homes for older adults, reflected in the Statement of Financial Entitlements.
- General Practice Staff Survey participation becomes mandatory for practices and PCNs, including sharing staff contact details with the ICB.
What the Process Question Means Legally
The characterisation of this year’s contract changes as a “consultation” rather than a negotiated agreement is more than a semantic point. In previous years, the annual contract has generally reflected a negotiated settlement between DHSC/NHS England and the BMA’s GPC England, subsequently implemented through statutory instruments amending the GMS Contracts Regulations 2015 and updates to the Statement of Financial Entitlements. Whether or not the BMA agrees to a given year’s terms does not, in itself, prevent those terms taking legal effect once the underlying regulations and directions are amended and in force. Practices are bound by the contract as varied by the regulations in force, not by whether their representative body consented to the process that produced them. For background on how the GMS, PMS and APMS contract framework operates and how it can be varied or terminated, see our post on NHS GP contracts explained. The financial detail behind these changes sits within the Statement of Financial Entitlements, which we cover separately in our post on recent legal changes to the SFE.
What This Means for Your Practice
The 2026/27 contract brings a genuine, if contested, funding uplift alongside firmer access requirements and a restructured route to practice-level GP recruitment. Given the unusual process behind this year’s changes, practices should not assume next year’s cycle will follow the same pattern, and should keep a close eye on how the underlying regulations and SFE directions are actually amended, rather than relying solely on the headline letter. We advise GP practices across London and the South East on the legal and contractual implications of each year’s GP contract changes. If you would like to discuss how the 2026/27 changes affect your practice, get in touch with our NHS regulatory team or call us on +44 207 566 1188. You can also reach us by email at info@gurvelegal.com.
